Table 1. Summary of Methods of Measuring Adherence.
Test | Example | Strength | Weakness |
---|---|---|---|
Direct method | |||
Measurement of the level of metabolite in blood or urine | Measurement of serum 6-TGN level; infliximab and vedolizumab trough levels | - Objective - Useful in case of primary nonresponse and secondary loss of response to biological agents |
- White coat adherence - Costly - Labor-intensive |
Indirect method | |||
Pill count | - | - Simple - Objective - Inexpensive |
- Could associate with overestimation or underestimation of adherence - Not suitable for medications administered in nondiscrete dosages or taken on an as-needed basis |
Pharmacy refill | Medication possession ratio, proportion of days covered method | - Objective - Relatively easy to obtain data |
- Not equivalent to consumption of medication - Requires a closed pharmacy system |
Electronic monitoring device | Medication Event Monitoring System | - Accurate - Results are easily quantified |
- Expensive system - Requires return visits of patients |
Patient self-report (e.g., patient-kept diaries, patient interviews, self-report questionnaires) | MMAS-4, MMAS-8, VAS, MARS-4 | - Simple - Inexpensive |
- Results could be easily manipulated by patients |
TGN, thioguanine nucleotides; MMAS, Morisky Medication Adherence Scale; VAS, Visual Analogue Scale; MARS, Medication Adherence Reporting Scale.